Business
CBN to go tough on bank accounts not linked to BVN
The Central Bank of Nigeria (CBN) is set to remove bank accounts not linked to the Bank Verification Number (BVN) system from the financial system in an effort to reduce fraud.
Blaise Ijebor, the Director of the Risk Management Department and Chief Risk Officer at CBN, announced this at the Prembly Compliance Breakfast Dialogue on Thursday.
Ijebor explained that cybercriminals exploit three loopholes in the system, including the use of Tier-1 accounts, which can be opened with minimal documentation and are not linked to BVN.
READ ALSO: Nigeria economy faces fiscal risk over CBN policies
These accounts have low deposit limits and are popular among unbanked populations, making them easy targets for fraudsters.
As of April 2, 2023, data on the NIBSS website indicates that there are only 57.01 million registered BVN numbers out of the total 191.4 million bank accounts in the country, with 133.5 million active.
Ijebor also highlighted the need for digital banks to comply with regulatory requirements and the importance of customers taking necessary cyber security measures.
He added that the CBN was working with the Nigerian Inter-Bank Settlement System to address the issue and plans to move Tier-1 accounts to Tier-2 with the help of agents who can assist with BVN registration.
However, Ijebor failed to give a timeline for the clean-up.
-
Football1 week agoXabi Alonso targets Arda Guler as Chelsea prepare €100m transfer bid
-
Football1 week agoFIFA confirms Jay-Jay Okocha holds World Cup record
-
Business7 days agoDangote cuts petrol, diesel prices again to boost affordability, economic activity
-
Aviation1 week agoInside Airport Luggage Theft: Experts warn of rising insider syndicates
-
Politics1 week agoAmuwo Odofin: Umeadi emerges winner of NDC Reps Primary
-
Featured1 week agoPSG edge Arsenal on penalties to retain Champions League crown
-
Football1 week agoChampions League Final: Talking points ahead of Arsenal vs. PSG match
-
Health4 days agoSenate hearing set to review research on COVID-19 vaccines, cancer concerns

